Feasibility Pilot Study to Evaluate the Safety and Performance of the MEX-CD1 Medical Device in Acute on Chronic Liver Failure (ACLF)
The goal of this clinical trial is to test the MEX-CD1 hemodialysis medical device in patients suffering from ACLF. The main questions it aims to answer are:
Is the device safe when used according to the instructions for use?
Does the device work as expected by removing the excess of free copper from the blood?
Patients will receive 3 MEX-CD1 Slow Low volume CVVHD within 1 week.
MEXWILS - Performance and Safety of MEX-CD1 Low-volume Continuous Veno-venous Haemodialysis Medical Device for Copper-extraction in Patients With Wilson's Disease
The goal of this clinical trial is to test the MEX-CD1 hemodialysis medical device in patients suffering from Wilson's Disease. The main questions it aims to answer are:
Does the device work as expected by removing the excess of free copper from the blood?
Is the device safe when used according to the instructions for use?
Depending on the severity of their symptoms, patients will receive either 5 or 10 treatments on consecutive days with the MEX-CD1 hemodialysis medical device.
100 Clinical Results associated with Mexbrain SAS
0 Patents (Medical) associated with Mexbrain SAS
100 Deals associated with Mexbrain SAS
100 Translational Medicine associated with Mexbrain SAS